http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17397704

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article|Research Support, Non-U.S. Gov't
endingPage 213
issn 1476-5586
issueIdentifier 2
pageRange 206-213
publicationName Neoplasia (New York, N.Y.)
startingPage 206
bibliographicCitation Langenberg MH, Witteveen PO, Lankheet NA, Roodhart JM, Rosing H, van den Heuvel IJ, Beijnen JH, Voest EE. Phase 1 study of combination treatment with PTK 787/ZK 222584 and cetuximab for patients with advanced solid tumors: safety, pharmacokinetics, pharmacodynamics analysis. Neoplasia. 2010 Feb;12(2):206–13. PMID: 20126478; PMCID: PMC2814358.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7888ac4af228aa1b7e5989527e2fbc49
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e4f75514daacc427a3e0d5b120dc1ed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cab6ac03b5e5e2fd2b9981b280a61e27
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ac97de523715622375e438f0c4e5732
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_487edceb9345982c5ff8d3348aabf586
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e8382f0ffe459308d8d1fa0907904a6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5a9021e4571e3695c51dbdf5bd0e80f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a0f126643756078ef10f1c0fe19c09f
date 201002
identifier https://pubmed.ncbi.nlm.nih.gov/20126478
https://doi.org/10.1593/neo.91864
https://pubmed.ncbi.nlm.nih.gov/PMC2814358
isPartOf https://portal.issn.org/resource/ISSN/1476-5586
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21648
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Phase 1 Study of Combination Treatment with PTK 787/ZK 222584 and Cetuximab for Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics Analysis
discusses http://id.nlm.nih.gov/mesh/M0016766
http://id.nlm.nih.gov/mesh/M0556300
http://id.nlm.nih.gov/mesh/M0422675
http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0358615
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D009369Q000188
http://id.nlm.nih.gov/mesh/D000971Q000627
hasSubjectTerm http://id.nlm.nih.gov/mesh/D042783Q000187
http://id.nlm.nih.gov/mesh/D000911Q000008
http://id.nlm.nih.gov/mesh/D005434
http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D061067
http://id.nlm.nih.gov/mesh/D010793Q000493
http://id.nlm.nih.gov/mesh/D010793Q000009
http://id.nlm.nih.gov/mesh/D013234Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011725Q000009
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D011725Q000493
http://id.nlm.nih.gov/mesh/D000911Q000493
http://id.nlm.nih.gov/mesh/D000911Q000009
http://id.nlm.nih.gov/mesh/D000068818
http://id.nlm.nih.gov/mesh/D002469
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D010793Q000008
http://id.nlm.nih.gov/mesh/D020714
http://id.nlm.nih.gov/mesh/D011725Q000008
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7453
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151194
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151193
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3a236e0877bf928b9d51ea42ef63147c
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22386467
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6777
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_49b3cbebbe7327885b176c8d75ecef43
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_966b69495aff24dd4bc4208192414e49
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5bf20507b757dd624886dac9baef5c7d
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8145

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129776330

Total number of triples: 75.